Investigation of the NMDA Antagonist Ketamine as a Treatment for Tinnitus

NCT03336398 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Tinnitus

Interventions

DRUG: Ketamine Hydrochloride in saline

Sponsor

New York State Psychiatric Institute